ADIPOQ and Insulin resistance: Preclinical studies have shown that SARS-CoV-2 infection induces adipocyte dysfunction (Fig. 1), causing a reduction in adiponectin expression that may contribute to systemic insulin resistance in individuals with severe COVID-19 (107).